Tasca Therapeutics
PrivateLast Round
Series A
Sep 16, 2025
Total Funding Raised
$144M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tasca Therapeutics is a biotechnology company that develops small molecule drugs for hard-to-treat oncology indications using a proprietary drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tasca Therapeutics Comparables
Compare Tasca Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Palm Therapeutics, Inc. | 84% | |
| BridGene Biosciences | 82% | |
| Antares Therapeutics | 81% |
Tasca Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 16, 2025 | ||||
| Series A | Dec 10, 2024 |
Tasca Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invus Opportunities | Series A |
| 8VC | Series A |
| Cure Ventures | Convertible Debt, Series A |
| Invus | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 39% MoM, reaching 2.7K.
- May 25, 2026
Grew 24% QoQ from 17 to 21 employees.
Tasca Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tasca Therapeutics's valuation, stock price, and market status.
Is Tasca Therapeutics a public or private company?
Tasca Therapeutics is a private company.
What is the current stock price of Tasca Therapeutics?
Tasca Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Tasca Therapeutics worth (valuation)?
Valuation information for Tasca Therapeutics is not publicly available.
Can I buy Tasca Therapeutics stock?
Tasca Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tasca Therapeutics's last funding round?
Tasca Therapeutics's most recent funding round was Series A on September 16, 2025.
Who are the main investors in Tasca Therapeutics?
Key investors in Tasca Therapeutics include Cure Ventures.
Will Tasca Therapeutics IPO soon?
No public IPO plans have been announced for Tasca Therapeutics.
How can I track Tasca Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tasca Therapeutics's secondary market activity and sign up for updates.